Remission, prediction and stability of symptoms in schizophrenia: A naturalistic 12-month follow-up study

被引:7
|
作者
Wolter, Arne [1 ,2 ]
Preuss, Ulrich Wolfgang [3 ]
Krischke, Norbert Richard [4 ]
Wong, Wei Mooi [3 ]
Zimmermann, Joerg [1 ]
机构
[1] Psychiatrieverbund Oldenburger Land gGmbH, Karl Jaspers Klin, Bad Zwischenahn, Germany
[2] Carl von Ossietzky Univ Oldenburg, Inst Psychol, Oldenburg, Germany
[3] Univ Halle Wittenberg, Klin Psychiatrie Psychotherapie Psychosomat, Halle, Germany
[4] Free Univ Berlin, Fachbereich Erziehungswissenschaft & Psychol, D-1000 Berlin, Germany
关键词
Schizophrenia; remission; follow-up; prediction; quality management; OUTPATIENT HEALTH OUTCOMES; PSYCHIATRIC RATING-SCALE; QUALITY-OF-LIFE; CRITERIA; VALIDATION; COHORT; IMPROVEMENT; RATIONALE; PSYCHOSIS; ILLNESS;
D O I
10.3109/13651500903531365
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective. Since its introduction in 2005, schizophrenia remission consensus criteria have been used in several prospective and cross-sectional studies. The aim of this prospective assessment of patients with schizophrenia was to employ the remission criteria in a naturalistic study design. Methods. One hundred and six patients with schizophrenia (ICD10 F 20. x) were enrolled into the study during inpatient treatment. Remission criteria with respect to changes in psychopathology ratings were obtained by trained interviewers at discharge and at 12-month follow-up using BPRS. Furthermore, information on social functioning and treatment-related quality of life were assessed using GAF (Global Assessment of Functioning) and SWN-K (Subjective Wellbeing under Neuroleptic Treatment Scale). Results. A total of 13.2% of the patients were found to meet remission criteria during follow-up. While there was no significant change in the mean BPRS scores, 14.2% of the subjects showed significant worsening and 29.2% significant improvement of their psychotic symptoms. Subsequent logistic regression analysis, explaining approximately 32% of symptomatic remission variance, indicated a significant influence of BPRS-Overall-Score and independent living at discharge. Conclusions. The results of this naturalistic study indicate that only a minority of former inpatients with schizophrenia achieve remission after 1 year and relevant subgroups of patients have significant bi-directional changes in symptoms during follow-up.
引用
收藏
页码:160 / 167
页数:8
相关论文
共 50 条
  • [1] A 12-month longitudinal naturalistic follow-up of cariprazine in schizophrenia
    Carmassi, Claudia
    Dell'Oste, Valerio
    Fantasia, Sara
    Bordacchini, Andrea
    Bertelloni, Carlo Antonio
    Scarpellini, Pietro
    Pedrinelli, Virginia
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [2] Olanzapine for the treatment of chronic refractory schizophrenia:: A 12-month follow-up naturalistic study
    Rodríguez-Pérez, V
    López, A
    Blanco, C
    Peña, C
    López, A
    Abel, A
    Gómez, Y
    Ferreiro, MJ
    Rego, C
    López, A
    Cudeiro, F
    Alvarez, V
    Prieto, R
    Ciudad, A
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (06): : 1055 - 1062
  • [3] Insight in Chinese schizophrenia patients: a 12-month follow-up
    Wang, Y.
    Xiang, Y. -T.
    Wang, C. -Y.
    Chiu, H. F. K.
    Zhao, J. -P.
    Chen, Q.
    Chan, S. S. M.
    Lee, E. H. M.
    Tang, W. -K.
    Ungvari, G. S.
    JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING, 2011, 18 (09) : 751 - 757
  • [4] Inpatient Treatment for Early Sexually Abused Adults: A Naturalistic 12-Month Follow-Up Study
    Jepsen, Ellen K. K.
    Langeland, Willie
    Sexton, Hal
    Heir, Trond
    PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY, 2014, 6 (02) : 142 - 151
  • [5] NEUROCOGNITIVE EFFECTS OF ATYPICAL AND CONVENTIONAL ANTIPSYCHOTIC DRUGS IN EARLY-STAGE SCHIZOPHRENIA: A NATURALISTIC 12-MONTH FOLLOW-UP STUDY
    Guo, X.
    Wang, B.
    Wang, C.
    Hu, B.
    Sun, X.
    Lv, L.
    Lu, Z.
    Ma, C.
    Guo, T.
    Xie, S.
    Liu, Z.
    Zhao, J.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [6] Naturalistic treatment of Alzheimer's disease with galantamine - 12-month follow-up from the NATURE study
    Brodaty, Henry
    Woodward, Michael
    Boundy, Karyn
    Barnes, Nicola
    CNS DRUGS, 2007, 21 (04) : 335 - 336
  • [7] MINDFULNESS MEDITATION AND COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA: A NATURALISTIC 12-MONTH FOLLOW-UP
    Ong, Jason C.
    Shapiro, Shauna L.
    Manber, Rachel
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2009, 5 (01) : 30 - 36
  • [8] The ASPECT clinical study - 12-month clinical follow-up
    Park, SJ
    Shim, WH
    Ho, D
    Raizner, AE
    CIRCULATION, 2002, 106 (19) : 394 - 394
  • [9] Donepezil for the treatment of cognitive impairment in residual schizophrenia: A 12-month follow-up
    Lenzi, A
    Maltinti, E
    Poggi, E
    Nassimbeni, A
    Del Poggetto, MC
    Coli, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S321 - S321
  • [10] ENTERYX® procedure:: 12-month follow-up of GERD symptoms and treatment satisfaction
    Brown, M
    Johnson, DA
    Pruitt, R
    Ganz, RA
    Radwin, M
    Mendolia, T
    Vakil, N
    Gostout, CJ
    DeLegge, M
    Pleskow, DK
    Chen, YK
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S47 - S48